Kiora Pharmaceuticals (KPRX)
(Delayed Data from NSDQ)
$4.23 USD
0.00 (0.00%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $4.18 -0.05 (-1.18%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.23 USD
0.00 (0.00%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $4.18 -0.05 (-1.18%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Zacks News
Is Kiora Pharmaceuticals (KPRX) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update
by Zacks Equity Research
Earnings results from Amgen (AMGN), Gilead (GILD) and others are the key highlights from the biotech sector during the past week.